Pharmadrug Inc.
PHRX
CNSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 110.70K | 111.90K | 58.60K | 71.40K | 81.30K |
| Depreciation & Amortization | 36.20K | 36.00K | 36.00K | 36.10K | 36.20K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 146.90K | 147.90K | 164.30K | 181.90K | 169.10K |
| Operating Income | -146.90K | -147.90K | -164.30K | -181.90K | -169.10K |
| Income Before Tax | -369.00K | -309.10K | -211.20K | -280.60K | -324.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.37 | -0.31 | -0.21 | -0.28 | -0.32 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 30.40K | 35.00K | 37.20K | 37.10K | 37.80K |
| Net Income | -338.50K | -274.00K | -174.00K | -243.60K | -286.90K |
| EBIT | -146.90K | -147.90K | -164.30K | -181.90K | -169.10K |
| EBITDA | -110.70K | -111.90K | -128.30K | -145.80K | -132.90K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 458.92M | 432.47M | 432.00M | 427.91M | 420.06M |
| Average Diluted Shares Outstanding | 458.92M | 432.47M | 432.00M | 427.91M | 420.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |